home / stock / prax / prax news


PRAX News and Press, Praxis Precision Medicines Inc. From 04/14/21

Stock Information

Company Name: Praxis Precision Medicines Inc.
Stock Symbol: PRAX
Market: NASDAQ
Website: praxismedicines.com

Menu

PRAX PRAX Quote PRAX Short PRAX News PRAX Articles PRAX Message Board
Get PRAX Alerts

News, Short Squeeze, Breakout and More Instantly...

PRAX - FBIO, GME, CRMD and RIG among midday movers

Gainers: Cinedigm (CIDM) +20%.Grupo Televisa (TV) +20%.GameStop (GME) +18%.Nurix Therapeutics (NRIX) +18%.Centennial Resource Development (CDEV) +17%.Regulus Therapeutics (RGLS) +16%.NexImmune (NEXI) +16%.UP Fintech (TIGR) +16%.Kymera Therapeutics (KYMR) +15%.Transocean (RIG) +...

PRAX - Praxis Precision Medicines' PRAX-562 treatment wins FDA 'orphan drug' status

Praxis Precision Medicines (PRAX) announces that the U.S. FDA has granted orphan drug designation for PRAX-562 for the treatment of SCN8A-DEE, a rare developmental and epileptic encephalopathy caused by a variant in the SCN8A gene.The FDA’s orphan drug designation program is ...

PRAX - Praxis Precision Medicines Receives Orphan Drug Designation for PRAX-562 for the Treatment of SCN8A-DEE

CAMBRIDGE, Mass., April 14, 2021 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system disorders (CNS) characterized by neuronal imbalance, tod...

PRAX - Seeking Alpha Catalyst Watch

Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week or the Seeking Alpha earnings calendar for companies due to report. Apri...

PRAX - Praxis Precision Medicines to Present at Stifel's 3rd Annual CNS Day

CAMBRIDGE, Mass., March 24, 2021 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system disorders (CNS) characterized by neuronal imbalance, tod...

PRAX - CRBP, BDSI, PRQR and MTRX among after-hours movers

Gainers: [[MTRX]] +13.1%. [[DSWL]] +8.7%. [[STRO]] +6.9%. [[GIFI]] +3.3%. [[PRQR]] +3%.Losers: [[FHTX]] -6.8%. [[CRBP]] -3%. [[PRAX]] -2.8%. [[AAME]] -2.6%. [[BDSI]] -2.6%. For further details see: CRBP, BDSI, PRQR and MTRX among after-hours movers

PRAX - Praxis Precision Medicines Inc. (PRAX) Q4 2020 Earnings Call Transcript

Image source: The Motley Fool. Praxis Precision Medicines Inc. (NASDAQ: PRAX) Q4 2020 Earnings Call Mar 17, 2021 , 8:00 a.m. ET Operator Continue reading For further details see: Praxis Precision Medicines Inc. (PRAX) Q4 2020 Earnings Cal...

PRAX - IDRA, CLVS, LX and MRKR among midday movers

Gainers: Clovis Oncology (CLVS) +61%.ZK International (ZKIN) +47%.SuperCom (SPCB) +47%.SenesTech (SNES) +45%.AudioEye (AEYE) +29%.Super League Gaming (SLGG) +27%.Marker Therapeutics (MRKR) +26%.Hall of Fame Resort & Entertainment (HOFV) +25%.X4 Pharmaceuticals (XFOR) +...

PRAX - Clovis Oncology, Marker Therapeutics leads healthcare gainers; Idera Pharmaceuticals, Praxis Precision Medicines among major losers

Gainers: Clovis Oncology (CLVS) +43%, Marker Therapeutics (MRKR) +23%, Alector (ALEC) +17%, Aravive (ARAV) +14%, Ortho Clinical Diagnostics (OCDX) +8%.Losers: Idera Pharmaceuticals (IDRA) -62%, Praxis Precision Medicines (PRAX) -13%,  Acu...

PRAX - Praxis Precision Medicines EPS misses by $0.49

Praxis Precision Medicines (PRAX): Q4 GAAP EPS of -$0.87 misses by $0.49.Cash and cash equivalents of $296.6MPress Release For further details see: Praxis Precision Medicines EPS misses by $0.49

Previous 10 Next 10